Delivery Order SPE2DB24D2101-SPE2DB25FKNBJ
Award Date 8/5/25
Potential Completion Date 8/6/25
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $3,012.98 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on September 11, 2025, with completion anticipated by September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $48,448.63 to AmerisourceBergen Drug Corp for the supply of Xeljanz 10 mg tablets (60-count units) with a completion date of September 29, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on September 26, 2025. The pharmaceutical will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents one...
- The Defense Logistics Agency awarded a delivery order valued at $18,065.90 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running...
- The Defense Logistics Agency awarded a delivery order valued at $18,191.81 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a direct fulfillment of pharmaceutical supply needs for federal medical procurement. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $10,095.81 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) under a firm fixed price contract. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,432.97 for Xeljanz 5 mg tablets (60-count units) on September 17, 2025, with completion scheduled for September 18, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the contractor's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $3,952.81 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-unit packaging) with a completion date of June 9, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a direct procurement of pharmaceutical products to support federal healthcare requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $73,540.08 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) with a completion deadline of April 30, 2025. This competitively awarded, firm fixed-price contract was issued on April 29, 2025, with no set-aside designation. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $20,512.96 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) under a firm fixed price contract. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $51,847.92 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) under a firm fixed-price contract type. This non-set-aside award was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order represents a single...